Northwest & Ethical Investments’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $658K | Buy |
23,832
+1,370
| +6% | +$37.8K | 0.02% | 375 |
|
2025
Q1 | $637K | Sell |
22,462
-21,004
| -48% | -$595K | 0.02% | 370 |
|
2024
Q4 | $1.81M | Buy |
43,466
+29,398
| +209% | +$1.22M | 0.05% | 261 |
|
2024
Q3 | $940K | Sell |
14,068
-1,387
| -9% | -$92.7K | 0.02% | 301 |
|
2024
Q2 | $1.84M | Hold |
15,455
| – | – | 0.05% | 254 |
|
2024
Q1 | $1.65M | Hold |
15,455
| – | – | 0.05% | 260 |
|
2023
Q4 | $1.54M | Hold |
15,455
| – | – | 0.05% | 250 |
|
2023
Q3 | $1.6M | Hold |
15,455
| – | – | 0.05% | 247 |
|
2023
Q2 | $1.88M | Buy |
15,455
+877
| +6% | +$107K | 0.06% | 250 |
|
2023
Q1 | $2.24M | Buy |
14,578
+1,983
| +16% | +$305K | 0.07% | 245 |
|
2022
Q4 | $2.26M | Buy |
12,595
+1,551
| +14% | +$279K | 0.08% | 234 |
|
2022
Q3 | $1.31M | Hold |
11,044
| – | – | 0.05% | 271 |
|
2022
Q2 | $1.58M | Buy |
11,044
+642
| +6% | +$91.7K | 0.06% | 261 |
|
2022
Q1 | $1.79M | Buy |
+10,402
| New | +$1.79M | 0.06% | 259 |
|